Association of IL8 polymorphisms with overall survival in patients with renal cell carcinoma in COMPARZ (pazopanib versus sunitinib phase III study) Meeting Abstract


Authors: Xu, C. F.; Johnson, T.; Choueiri, T. K.; Deen, K. C.; Xue, Z.; Spraggs, C. F.; Bartlett-Pandite, A. N.; Carpenter, C.; Motzer, R. J.
Abstract Title: Association of IL8 polymorphisms with overall survival in patients with renal cell carcinoma in COMPARZ (pazopanib versus sunitinib phase III study)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419601533
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.4519
Notes: Meeting Abstract: 4519 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer